The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Research on SLE, pJIA & More Highlighted in 2nd ACR Convergence 2021 Plenary Session

Research on SLE, pJIA & More Highlighted in 2nd ACR Convergence 2021 Plenary Session

December 9, 2021 • By Samantha C. Shapiro, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

ACR CONVERGENCE 2021—The Plenary Sessions highlighted select abstracts of interest to the general ACR audience. This year at Plenary Session 2, six researchers shared highlights from their work.

You Might Also Like
  • ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings
  • Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session
  • Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’
Also By This Author
  • Multidisciplinary Guidance for Pulmonary Disease in Sjögren’s Syndrome

Racial Disparities in Renal Outcomes in Children with SLE

Joyce Chang, MD, MSCE

Dr. Joyce Chang

Joyce Chang, MD, MSCE, assistant professor of pediatrics, Harvard Medical School, Boston, kicked off the session talking about a study characterizing trends in renal outcomes over time among hospitalized children with systemic lupus erythematosus (SLE). The researchers tested whether racial disparities in renal outcomes have changed over time.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“New advances in therapeutics and care quality guidelines could narrow disparities by reducing variation or widen them if advances do not reach groups equally,” she said.

In the study, researchers found a statistically significant decrease in SLE hospitalizations associated with adverse renal outcomes overall, reflecting progress in pediatric lupus care. On average, improvements were similar in each racial/ethnic group. However, relative Black-white disparity persists, and the magnitude of disparities may vary by hospital catchment area.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

So where do we go from here? Dr. Chang noted that a “focus on improving care quality alone won’t be sufficient to close the gap in racial disparities, and we need to know root causes in order to identify processes that preferentially improve outcomes among highest risk groups.”

For next steps, she recommended “systematic collection of local data on individual and area-level social determinants of health to understand why differential risks occur.”

Effects of Vitamin D & Fish Oil

Karen Costenbader, MD, MPH

Dr. Karen Costenbader

Karen H. Costenbader, MD, MPH, professor of medicine, Harvard Medical School, and director of the Lupus Program, Brigham and Women’s Hospital, Boston, presented results from the Vitamin D and Omega-3 trial (VITAL), which studied the use of vitamin D and fish oil for the prevention of autoimmune diseases.2

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Despite the significant burden of illness of autoimmune diseases, no current preventive measures are at the rheumatologist’s disposal.

Vitamin D and omega-3 fatty acids, commonly known as fish oils due to their abundance in fish, have long been of interest to the scientific community. However, no prospective randomized trials have tested the effects of vitamin D or fish oil supplementation on the incidence of autoimmune disease over time.

VITAL was a randomized controlled trial of more than 25,000 patients who received 2,000 international units of vitamin D daily and 1 g of fish oil daily vs. placebo for the prevention of autoimmune disease in adults. The primary outcome was all incident autoimmune diseases determined via participant self-reporting and extensive medical record review for diagnoses and criteria.

Pages: 1 2 3 4 5 | Single Page

Filed Under: ACR Convergence, Conditions, Meeting Reports, SLE (Lupus) Tagged With: ACR Convergence 2021, ACR Convergence 2021 – SLE, COVID-19, MIS-C, Pediatric, pJIA, polyarticular juvenile idiopathic arthritis

You Might Also Like:
  • ACR Convergence 2020 Kicks Off: Plenary session speakers highlight racial differences in lupus & COVID-19-related findings
  • Advances in Rheumatology & Challenges that Remain Spotlighted in ACR Convergence 2021 Closing Session
  • Gout Research at a Glance: ‘My picks for the top research in gout presented at ACR Convergence 2021’
  • Opening Session of ACR Convergence 2021 Takes on Burnout, Pandemic Challenges & Moving Toward a New Normal

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)